Brainomix 360 Stroke

Brain CT and MRI analysis that assists in treatment decisions around key perfusion therapies.

Book a meeting
Braonomix 360

Overview

Brainomix 360 Stroke is a comprehensive, secure AI imaging solution that supports clinicians to make faster, more confident treatment decisions from any imaging modality in the acute stroke pathway.

e-Stroke / 360* - brainomix logo

Features

  • e-ASPECTS module provides automated ASPECTS scoring and identification of affected areas contributing to ASPECTS score.
  • e-CTP module provides hemodynamic maps (rCBV, rCBF, MTT, TTP, Tmax/Delay), and automatic identification and volume estimation of ischemic core and tissue-at-risk.
  • e-CTA module provides assessment of collaterals (% score), vessel MIIPs, multi-planar reconstructions, AIF/VOF curves (phase assessment for acquisition quality assurance) on CT angiography and detects large vessel occlusions (LVO).
  • e-MRI processes Diffusion Weighted Imaging (DWI) MR series to generate diffusion parameter maps, identify areas with restricted diffusion, and includes automated mismatch, phase assessment, and motion correction.
  • Option to view imaging with or without annotations in web or mobile UI.
  • Trials Tracker – embedded assessment of patient inclusion criteria for landmark trials and user-defined benchmarks.
  • Messaging & calling – enables secure coordination for each case to review and share images & patient data.
  • Flag for thrombectomy – send a notification to signal that a patient is eligible for thrombectomy with one-click.

Benefits

  • A study found that the implementation of Brainomix 360 Stroke reduced door-in-door-out (DIDO) times by more than 1 hour and tripled the number of stroke patients achieving functional independence from 16% to 28% (mRS 0-2 @ 90 days)¹
  • A health economic analysis by York University found that the implementation of Brainomix 360 Stroke is highly cost effective, with an incremental cost-effectiveness ratio (ICER) of £5,165 – well below the £20,000 threshold set by the UK’s National Health Service (NHS)²
  • Aims to increase the confidence of non-stroke specialists in making referral decisions.
  • Potential to improve communication between on-call interventionists and stroke staff.
  • e-MRI provides advanced imaging assessments for acute ischemic stroke, particularly for late-window patients eligible for thrombolysis and thrombectomy3. 

Image examples

e-CTA-1024x528
e-CTP
e-MRI

To find out more about this solution or any of the other 140+ applications on the Blackford Platform, please book a discovery call with our team.

review image 1

Book a meeting

We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.

Book a Meeting

¹Nagaratnam K. Artificial Intelligence Clinical Decision Aid Tool Shortens Time in Mechanical Thrombectomy Pathway. International Journal of Stroke 2021, Vol. 16(2S) 28.

²Green W. Brainomix: Economic Evaluation of the e-Stroke Suite, Final Report. York Health Economics Consortium, November 2020.

3Manishkumar. Brainomix launches Brainomix 360 platform for stroke care in US [Internet]. NS Medical Devices. 2023 [cited 2024 Jul 5]. Available from: https://www.nsmedicaldevices.com/company-news/brainomix-launches-brainomix-360-platform-for-stroke-care-in-us/?cf-view